National Development and Research Institutes, Inc and Public Health Solution, 71 West 23rd Street, New York, NY 10010, USA.
Subst Abuse Treat Prev Policy. 2011 Apr 11;6:7. doi: 10.1186/1747-597X-6-7.
Human xylazine use in Puerto Rico merits particular attention for its unprecedented scale and depth. Although Puerto Rican injecting drug users (IDUs) have reported using this drug since the early 2000s, little is being done in the research and service delivery sectors as it is claimed that xylazine severely impacts the health of its users. This report provides information on xylazine use and its associated harms. Data from one semi-structured interview collected in New York City (2007-2008) as part of a larger research study with migrant Puerto Rican drug users is presented as a case study. Xylazine, a veterinary sedative, is an adulterant and complement to other drugs and its chronic use is reported to be associated with physical deterioration. Because human xylazine use has been reported in other locations outside of Puerto Rico, this substance could also emerge as an adulterant in other markets to the levels currently experienced in Puerto Rico. Research and interventions are needed to provide adequate services on the island, better understand how the use of xylazine affects its users, and to reduce the possibility of increased xylazine use on the state-side.
波多黎各的人类使用苯环己哌啶现象值得特别关注，因为其规模和深度前所未有。尽管自 21 世纪初以来，波多黎各的注射吸毒者（IDU）就报告称使用过这种药物，但在研究和服务提供领域几乎没有采取任何措施，因为据称苯环己哌啶会严重影响使用者的健康。本报告提供了有关苯环己哌啶使用及其相关危害的信息。作为一项针对移民波多黎各吸毒者的更大研究的一部分，于 2007 年至 2008 年在纽约市收集的一次半结构化访谈中的数据被作为案例研究呈现。苯环己哌啶是一种兽医镇静剂，是其他药物的掺杂物和补充剂，其长期使用据称与身体恶化有关。由于已经在波多黎各以外的其他地方报告了人类使用苯环己哌啶的情况，因此这种物质也可能会在其他市场作为掺杂物出现，达到目前在波多黎各的水平。需要进行研究和干预，以在该岛提供足够的服务，更好地了解苯环己哌啶的使用如何影响其使用者，并降低该州苯环己哌啶使用增加的可能性。
